Back to News
Market Impact: 0.25
Jasper Therapeutics To Implement 1-for-30 Reverse Stock Split
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
asper Therapeutics announced a 1-for-30 reverse split of its issued and outstanding common stock, effective at 12:01 a.m. Eastern Time on November [date not provided in the supplied text]. The article excerpt gives no additional rationale or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
JSPR-0.35
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Snap shares fall over 10% on third-quarter earnings miss
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Drone Attacks Spawn New Insurance Market in Baltics, Poland
- REA Group shares rally on strong Q1 revenue